companydata.dkcompanydata.dk

NORDIC BIOTECH ADVISORS ApS: Financial statements 2016

CVR: 26123925

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

NORDIC BIOTECH ADVISORS ApS (CVR 26123925) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 3,717,818 and a net result of DKK 569,324 compared with DKK 273,702 the year before. That is an increase of 2.8% compared with the year before. Equity in the 2016 report amounted to DKK 2,056,085. The solvency ratio was 73.3%.

Gross Profit
DKK 3,717,818
Profit/Loss
DKK 569,324
Equity
DKK 2,056,085
Total Assets
DKK 2,805,990

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-3.7M569K2.1M-
2015-3.6M274K1.5M-
2014-2.8M-162K1.2M-
2013-3.6M9K1.4M-
2012-3.8M-63K1.4M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like NORDIC BIOTECH ADVISORS ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2016

NORDIC BIOTECH ADVISORS ApS: The 2015 annual report is outJun 10, 2016

NORDIC BIOTECH ADVISORS ApS has published its annual report for 2015. Gross profit came to DKK 3,618,211, and the net result was DKK 273,702.

About NORDIC BIOTECH ADVISORS ApS

NORDIC BIOTECH ADVISORS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is registered under the industry Andre aktiviteter i forbindelse med finansielle tjenesteydelser, undtagen forsikring og pensionsforsikring. The company was previously named NEXGEN BIOTECH ApS and NORDIC BIOTECH ApS. The management consists of Florian Schønharting. The board consists of Florian Schønharting and Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS, C. HANSEN INVEST ApS and BVF/Nexgen Biotech, LP. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,273,154 and a net result of DKK 360,368 compared with DKK -572,578 the year before. Equity in the 2025 report amounted to DKK 4,622,219.

Source: annual report 2025, Danish Business Authority